News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Longer-Term Clinical Trial Findings Show Significant Reduction in Blood Pressure, Improvement in Heart Function with CVRx, Inc. Rheos(R) System


3/30/2009 9:45:04 AM

MINNEAPOLIS & ORLANDO, Fla.--(BUSINESS WIRE)--CVRx announced today that longer-term data from early Rheos clinical studies show significant reductions in hypertension and improvements in heart structure and function. The Rheos® Hypertension System, developed by the Minneapolis-based company, is the first device designed to treat hypertension, a leading cause of heart and kidney disease, stroke and death. The Rheos System activates the carotid baroreflex, the body’s own system for regulating blood pressure, and may provide a future treatment option for the millions of people who cannot control their high blood pressure (hypertension) with medications.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES